11 pending office actions • 2 clients
| Client (Assignee) | Pending OAs |
|---|---|
| Momenta Pharmaceuticals, Inc. | 8 |
| Takeda Pharmaceutical Company Limited | 3 |
| App # | Title | Client | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|---|
| 18691573 | FACILITATED DELIVERY OF CONCENTRATED ANTIBODY FORMULATIONS USING HYALURONIDASE | Takeda Pharmaceutical Company Limited | HOLLAND, PAUL J | 1656 | Non-Final OA | Mar 13, 2024 |
| 18218996 | Sialylated Glycoproteins | Momenta Pharmaceuticals, Inc. | HADDAD, MAHER M | 1641 | Non-Final OA | Jul 06, 2023 |
| 18218535 | Sialylated Glycoproteins | Momenta Pharmaceuticals, Inc. | FAUST, AMBER KATHLEEN | 1643 | Non-Final OA | Jul 05, 2023 |
| 18217401 | Sialylated Glycoproteins | Momenta Pharmaceuticals, Inc. | LEONARD, ARTHUR S | 1631 | Non-Final OA | Jun 30, 2023 |
| 18136803 | Sialylated Glycoproteins | Momenta Pharmaceuticals, Inc. | D' AMBROSIO, THEA | 1654 | Final Rejection | Apr 19, 2023 |
| 18022069 | SIALYLATED GLYCOPROTEINS | Momenta Pharmaceuticals, Inc. | KIM, YUNSOO | 1641 | Non-Final OA | Feb 17, 2023 |
| 18022061 | HYPERSIALYLATED IMMUNOGLOBULIN | Momenta Pharmaceuticals, Inc. | BOWERS, ERIN M | 1653 | Non-Final OA | Feb 17, 2023 |
| 17925999 | HYPER-SIALYLATED IMMUNOGLOBULIN | Momenta Pharmaceuticals, Inc. | GAO, ASHLEY HARTMAN | 1678 | Final Rejection | Nov 17, 2022 |
| 17909282 | METHODS OF MAKING HYPER-SIALYLATED IMMUNOGLOBULIN | Momenta Pharmaceuticals, Inc. | RAGHU, GANAPATHIRAM | 1652 | Final Rejection | Sep 02, 2022 |
| 17556857 | PURIFICATION OF FVIII FROM PLASMA USING SILICON OXIDE ADSORPTION | Takeda Pharmaceutical Company Limited | ESPINOSA, CLAUDIA EDILMA | 1654 | Non-Final OA | Dec 20, 2021 |
| 17169835 | SEPARATION OF VWF AND VWF PROPEPTIDE BY CHROMATOGRAPHIC METHODS | Takeda Pharmaceutical Company Limited | STEELE, AMBER D | 1658 | Non-Final OA | Feb 08, 2021 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial